Dr. Chatterjee is the Vice President of Medicinal Chemistry at Calibr, the biotechnology division of Scripps Research. Listen as we talk about re-purposing existing compounds for new diseases, the future of robotics in drug discovery and our favorite Superheroes.
Show notes:
About Calibr
https://www.scripps.edu/science-and-medicine/calibr/about/index.html
ReFRAME Initiative
https://www.scripps.edu/news-and-events/press-room/2018/20181003-reframe-calibr.html
Footage of Calibr’s robots in action
https://www.statnews.com/2018/12/10/calibr-drug-compounds-mined-new-treatments/
Use of the ReFRAME library to treat Cryptosporidium infection
https://www.pnas.org/content/115/42/10750
